Literature DB >> 27380339

Deutetrabenazine for Treatment of Chorea in Huntington Disease.

Michael D Geschwind1, Nick Paras1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27380339     DOI： 10.1001/jama.2016.8011

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

Review 1.  Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease.

Authors:  Young-A Heo; Lesley J Scott
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

2.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

Review 3.  A Brief Review on the Role of Vesicular Monoamine Transporter2 Inhibitors in Hyperkinetic Movement Disorders.

Authors:  Ali Nikkhah
Journal:  Iran J Child Neurol       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.